Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune response in the intestinal mucosa refers to the complex network of innate and adaptive immune mechanisms that protect the gut from pathogens, maintain tolerance to harmless antigens (such as food and commensal bacteria), and preserve intestinal homeostasis. This system includes physical barriers (epithelial lining, mucus layer), Gut-Associated Lymphoid Tissue (GALT), mucosal immune cells (dendritic cells, T cells, B cells, ILCs), and secretory IgA (SIgA). Key mechanisms involve pattern recognition receptors (TLRs), cytokine signaling, and regulation by regulatory T cells. Disruption or dysregulation can lead to inflammatory bowel diseases, food allergies, and increased susceptibility to infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune Response (Intestinal Mucosa).